Illinois

Exploratory Analysis of the Phase I/II CHRYSALIS Study of gilteritinib Demonstrates First Molecular Response to FLT3 Inhibitor in Acute Myeloid Leukemia

NORTHBROOK, Ill., June 6, 2017 /PRNewswire/ -- Astellas today announced data from an exploratory analysis of the Phase I/II CHRYSALIS study, which demonstrated that FLT3 mutation-positive relapsed/refractory (R/R) acute myeloid leukemia…
Continue Reading »
Illinois

Physician-Patient Alliance for Health & Safety Releases Position on Continuous Electronic Monitoring During Opioid Use

CHICAGO, June 6, 2017 /PRNewswire/ -- The Physician-Patient Alliance for Health & Safety (PPAHS) has released a position paper calling for continuous electronic monitoring for patients undergoing moderate and conscious…
Continue Reading »